about
New approach for food allergy management using low-dose oral food challenges and low-dose oral immunotherapiesRecent advances in component resolved diagnosis in food allergyWorld Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) GuidelinesXXIV World Allergy Congress 2015In-flight allergic emergencies.Japanese guidelines for childhood asthma 2017.EAACI Molecular Allergology User's Guide.Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization StatementLarge scale genotyping study for asthma in the Japanese population.International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem.International consensus on (ICON) anaphylaxisReactions of Buckwheat-Hypersensitive Patients during Oral Food Challenge Are Rare, but Often Anaphylactic.Risk Factors for Severe Reactions during Double-Blind Placebo-Controlled Food ChallengesWorld Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base.2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.Cross-talk between integrins and chemokines that influences eosinophil adhesion and migration.World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics.Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma.Intermittent and episode-driven use of pranlukast to reduce the frequency of wheezing in atopic children: a randomized, double-blind, placebo-controlled trial.Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks.A consensus protocol for the determination of the threshold doses for allergenic foods: how much is too much?Do Longer Intervals between Challenges Reduce the Risk of Adverse Reactions in Oral Wheat Challenges?Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants.World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): PrebioticsAsthma diagnosis and treatment - 1005. Optimization for the withdrawal of inhaled corticosteroid treatment by monitoring fractional exhaled nitric oxide (feno) and lung functions.World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Vitamin D.Guidelines for diagnosis and management of pediatric food allergy in Japan.Allergenicity assessment of genetically modified crops--what makes sense?Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review.Heated egg yolk challenge predicts the natural course of hen's egg allergy: a retrospective study.A global survey of changing patterns of food allergy burden in children.Management of food allergy in Japan "food allergy management guideline 2008 (revision from 2005)" and "guidelines for the treatment of allergic diseases in schools".Precautionary labelling of foods for allergen content: are we ready for a global framework?Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report.Japan food allergen labeling regulation--history and evaluation.Cow's milk allergy as a global challenge.Japanese guideline for food allergy.Use of allergen components begins a new era in pediatric allergology.ICON: food allergy.2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis.
P50
Q26771636-321F5CB9-339C-4280-9CC1-25157014020CQ26829898-61EF5BC4-D4BA-4953-A526-C5C7A7872F1FQ28282226-13E81D7B-DF6C-4C44-BD35-8FCBA6908D02Q28550026-EF657B9B-9801-409B-BF42-63449C6E2DC8Q30234491-E1AA5A7E-61E7-4AFB-A6F8-B3A946A9F7ADQ30238904-EAC0407F-341D-412C-BAF0-BEE3B3A81126Q30276634-10C6E966-F100-4611-92AF-D9020BD74A53Q30371972-A56397A8-D477-4962-A539-07C9A832D508Q33424968-91F799BB-050B-4661-9C08-16CD6BA31E95Q33572979-953BC24D-FA50-4CC6-BAC6-842B87B9CB3AQ33687257-DA78A912-E534-4895-BD33-403971169CC4Q33749739-0845A52F-5671-4EAB-8BC6-C9747C444D31Q33810719-29C5C3F9-1256-4B02-8D19-77135D339385Q34368942-BCC294DA-20ED-4357-8719-08E807F912F4Q34500152-A4BD4EC4-17B1-45C1-8350-E0EB42D29501Q34686758-E7FD2CA3-6BB7-46CD-970D-DC4B66172F98Q35018033-0404BD1F-EC0D-4509-8A35-808314B7D2A7Q35173486-79446A7A-EC2C-4256-9C23-88892FB1E9B5Q35245929-BB31373E-D160-45FD-94F2-484E7599C56DQ35568959-6268FB6A-7668-423F-A976-0E6A45AAC3D9Q35773650-35351634-0815-4900-A234-E334AF35820EQ35856857-D232600A-4C9A-4108-B7A2-4018F91070FDQ35910715-91CCF540-A9D4-4428-9A12-EC26DC18DB38Q36634601-4B9BFAFA-36A3-4725-961A-BAF21142C006Q36813912-856FC824-122F-464D-B44E-1315F17BA78CQ36907237-BE2D8803-DA83-47C6-BE0E-7D00BEE1F097Q36983619-FD3689B1-1577-4FDE-8DE4-711C5D8A80A6Q37053552-5FDC6129-94A2-4EB7-B451-7E51CDD5B847Q37064447-CA52914D-5FDD-4334-8BD7-E3DEFABA8073Q37316684-D9511927-C01B-40A9-BF63-327FA6DAF52EQ37427644-F6738B30-D4FF-4CEB-A14E-E7734820FABFQ37619205-060BA5F8-BF2F-4A69-B4F8-4B8D2DF1C8B1Q37734293-B8700ACD-24FF-42B8-987E-26E8A00B9F54Q37816624-7AEF0914-0E16-4CE7-9781-8A2ABF55C218Q37866888-505BA7B4-284F-4C26-834B-80179DF21A09Q37869322-EFF3E02C-FA07-41E7-95D4-3CB55D5ABB14Q37884332-F9A23B33-57DE-41B5-8C43-EED9FE86378FQ37902692-45BC9D16-B242-4F48-9533-6270FEE5F185Q37988174-593A2A02-791D-445B-A273-F5274319F6FBQ38022499-AEC420F7-C0D5-4DEC-A1A0-31CF3F0C0D1E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Motohiro Ebisawa
@ast
Motohiro Ebisawa
@en
Motohiro Ebisawa
@es
Motohiro Ebisawa
@nl
Motohiro Ebisawa
@sl
type
label
Motohiro Ebisawa
@ast
Motohiro Ebisawa
@en
Motohiro Ebisawa
@es
Motohiro Ebisawa
@nl
Motohiro Ebisawa
@sl
prefLabel
Motohiro Ebisawa
@ast
Motohiro Ebisawa
@en
Motohiro Ebisawa
@es
Motohiro Ebisawa
@nl
Motohiro Ebisawa
@sl
P106
P31
P496
0000-0003-4117-558X